Kim Coppom

Kim Coppom is an accomplished leader in the pharmaceutical industry with extensive experience in market access and payer strategy. Currently serving as Executive Director of National Accounts and Federal Markets at AVEO Oncology since January 2024, Kim leads teams to ensure optimal access to the company's product portfolio. Prior roles include Head of US Managed Markets at Vifor Pharma, where responsibilities encompassed overseeing a team and implementing payer strategies, and Senior Director of Account Management at Sobi, focusing on business growth and patient service strategies. Previous positions at Intarcia Therapeutics and AstraZeneca involved market development and contract negotiations with key stakeholders. Kim's career began at Sanofi, where a series of roles led to significant sales achievements and recognition for outstanding performance. Kim earned a BS in Business from California State University, Fresno.